Literature DB >> 34590912

Exercise prevents whole body type 2 diabetes risk factors better than estradiol replacement in rats.

Luke J Fritsch1, Skylar J McCaulley2, Colton R Johnson3, Nicholaus J Lawson3, Brittany K Gorres-Martens4.   

Abstract

The absence of estrogens in postmenopausal women is linked to an increased risk of type 2 diabetes (T2D) and estradiol replacement can decrease this risk. Notably, exercise can also treat and prevent T2D. This study seeks to understand the molecular mechanisms by which estradiol and exercise induce their beneficial effects via assessing whole body and cellular changes. Female Wistar rats were ovariectomized and fed a high-fat diet for 10 wk and divided into the following four experimental groups: 1) no treatment (control), 2) exercise (Ex), 3) estradiol replacement, and 4) Ex + estradiol. Both Ex and estradiol decreased the total body weight gain. However, only exercise effectively reduced the white adipose tissue (WAT) weight gain, food intake, blood glucose levels, and serum insulin levels. At the molecular level, exercise increased the noninsulin-stimulated pAkt levels in the WAT. In the liver, estradiol increased the protein expression of acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS) and estradiol decreased the hepatic protein expression of lipoprotein lipase (LPL). In the WAT, estradiol and exercise increased the protein expression of adipose triglyceride lipase (ATGL). Exercise provides better protection against T2D when considering whole body measurements, which may be due to increased noninsulin-stimulated pAkt in the WAT. However, at the cellular level, several molecular changes in fat metabolism and fat storage occurred in the liver and WAT with estradiol treatment.NEW & NOTEWORTHY Exercise provides better protection than estradiol against type 2 diabetes when considering whole body measurements including adipose tissue weight, blood glucose levels, and serum insulin levels, which may be due to increased noninsulin-stimulated pAkt in the adipose tissue. However, at the cellular level, several molecular changes in fat metabolism and fat storage occurred in the liver and adipose tissue with estradiol treatment.

Entities:  

Keywords:  estradiol; fat metabolism; high-fat diet; prescribed exercise

Mesh:

Substances:

Year:  2021        PMID: 34590912      PMCID: PMC8616605          DOI: 10.1152/japplphysiol.00098.2021

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  47 in total

1.  Myocellular triacylglycerol breakdown in females but not in males during exercise.

Authors:  Charlotte H Steffensen; Carsten Roepstorff; Marianne Madsen; Bente Kiens
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-03       Impact factor: 4.310

2.  17beta-estradiol supplementation decreases glucose rate of appearance and disappearance with no effect on glycogen utilization during moderate intensity exercise in men.

Authors:  Michaela C Devries; Mazen J Hamadeh; Terry E Graham; Mark A Tarnopolsky
Journal:  J Clin Endocrinol Metab       Date:  2005-08-23       Impact factor: 5.958

3.  Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways.

Authors:  Tara M D'Eon; Sandra C Souza; Mark Aronovitz; Martin S Obin; Susan K Fried; Andrew S Greenberg
Journal:  J Biol Chem       Date:  2005-08-17       Impact factor: 5.157

4.  Insulin resistance of obese Zucker rats exercise trained at two different intensities.

Authors:  M Y Cortez; C E Torgan; J T Brozinick; J L Ivy
Journal:  Am J Physiol       Date:  1991-11

5.  Estrogen suppresses transcription of lipoprotein lipase gene. Existence of a unique estrogen response element on the lipoprotein lipase promoter.

Authors:  H Homma; H Kurachi; Y Nishio; T Takeda; T Yamamoto; K Adachi; K Morishige; M Ohmichi; Y Matsuzawa; Y Murata
Journal:  J Biol Chem       Date:  2000-04-14       Impact factor: 5.157

6.  Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial.

Authors:  K L Margolis; D E Bonds; R J Rodabough; L Tinker; L S Phillips; C Allen; T Bassford; G Burke; J Torrens; B V Howard
Journal:  Diabetologia       Date:  2004-07-14       Impact factor: 10.122

7.  Modulation of insulin resistance in ovariectomized rats by endurance exercise training and estrogen replacement.

Authors:  Vitoon Saengsirisuwan; Somrudee Pongseeda; Mujalin Prasannarong; Kanokwan Vichaiwong; Chaivat Toskulkao
Journal:  Metabolism       Date:  2009-01       Impact factor: 8.694

Review 8.  The emergence of the metabolic syndrome with menopause.

Authors:  Molly C Carr
Journal:  J Clin Endocrinol Metab       Date:  2003-06       Impact factor: 5.958

9.  Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency.

Authors:  K Takeda; K Toda; T Saibara; M Nakagawa; K Saika; T Onishi; T Sugiura; Y Shizuta
Journal:  J Endocrinol       Date:  2003-02       Impact factor: 4.286

Review 10.  Postmenopausal hormone replacement therapy: scientific review.

Authors:  Heidi D Nelson; Linda L Humphrey; Peggy Nygren; Steven M Teutsch; Janet D Allan
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

View more
  1 in total

1.  Estrogen receptor α activation modulates the gut microbiome and type 2 diabetes risk factors.

Authors:  Janelle A Shiffler; Krista A Goerger; Brittany K Gorres-Martens
Journal:  Physiol Rep       Date:  2022-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.